Future possibilities in the prevention of breast cancer: Luteinizing hormone-releasing hormone agonists

The cyclic production of estrogen and progesterone by the premenopausal ovary accounts for the steep rise in breast cancer risk in premenopausal women. These hormones are breast cell mitogens. By reducing exposure to these ovarian hormones, agonists of luteinizing hormone-releasing hormone (LHRH) gi...

Descripción completa

Detalles Bibliográficos
Autores principales: Spicer, Darcy V, Pike, Malcolm C
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2000
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC138786/
https://www.ncbi.nlm.nih.gov/pubmed/11250719
http://dx.doi.org/10.1186/bcr67

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC138786/
https://www.ncbi.nlm.nih.gov/pubmed/11250719
http://dx.doi.org/10.1186/bcr67

Ejemplares similares